Investing Profile

Martijn Kleijwegt

VCInvestor
Partner at EQT Life Sciences
eqtgroup.com/about/people/mar...Amsterdam, Netherlands
Photo of Martijn Kleijwegt, Partner at EQT Life Sciences
Your Intro Paths to Martijn Kleijwegt
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Martijn Kleijwegt on

cb
Current Investing Position
EQT Life Sciences Partner
Investment Range
$11.0M - $65.0M
Sweet Spot
$25.0M
Investments On Record
9
Current Fund Size
€260M

Martijn Kleijwegt is on these Sector & Stage Rankings

Martijn Kleijwegt's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
PanTera
Series ASep 2024$110M
$110M
Vico Therapeutics
Series BJan 2024$72M
Series AJul 2020$31M
$120M
Co-investors: Amy Schulman (Polaris Partners), Felice Verduyn - van Weegen (EQT Life Sciences), Rémi Droller (Kurma Partners), Silvia Noiman (Pontifax Venture Capital), Jean-François Rivassou (Kurma Partners)
AM Pharma
Series FJul 2019$130M
$210M
Co-investors: Raphael Wisniewski (Andera Partners), Geert-Jan Mulder (Forbion), Rémi Droller (Kurma Partners), Joël Jean-Mairet (Ysios Capital), Felice Verduyn - van Weegen (EQT Life Sciences), Laia Crespo (Sanofi Ventures)
Eloxx
Series CAug 2017$8M
$38M
Co-investors: Janice Bourque (Hercules Capital)
Orphazyme
Series UnknownMar 2017$15M
$15M
Prosensa
Series UnknownJan 2012$30M
Series AFeb 2007$18M
$48M
Co-investors: David Mott (Mott Family Capital)
ActoGeniX
Series UnknownSep 2006$25M
$25M